Clinical Trial Results: Falls: A Marker of Preclinical AD

View source ↗

Summary

Completed clinical trial examining falls as a marker of preclinical Alzheimer disease and reporting results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: Washington University School of Medicine | Conditions: Fall, Alzheimer Disease | Status: COMPLETED | Results posted: 2026-07-22